Skip to main content

Xtant Medical Holdings, Inc 8-K, filed Nov 16, 2026

Xtant Medical Holdings, Inc. (XTNT)

8-K 2026-11-16 For: 2026-11-16
View Original
Added on November 16, 2026

About this 8-K

Xtant Medical Holdings, Inc filed this 8-K on November 16, 2026.

Xtant Medical launched a board-led strategic review after missing guidance for a second consecutive quarter. Third-quarter revenue was $24.3 million, net loss was $3.6 million, adjusted EBITDA was a loss of $1.5 million, and previously issued full-year 2026 guidance will not be achieved. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits